Picture of Miravant Medical Technologies logo

MRVT Miravant Medical Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Miravant Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2000
December 31st
2001
December 31st
2002
December 31st
2003
December 31st
2004
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-26-16.4-16-7.46-15.9
Depreciation
Non-Cash Items7.314.452.68-4.154.18
Unusual Items
Other Non-Cash Items
Changes in Working Capital3.57-4.493.820.241-0.069
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-13.4-15.2-8.57-10.8-11.5
Capital Expenditures-0.462-0.354-0.154-0.306-0.323
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-15.315.14.721.62-2.98
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-15.814.84.571.31-3.3
Financing Cash Flow Items0-0.3-0.155-0.3140.108
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities11.90.0153.269.8216.9
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-17.2-0.477-0.7350.3072.08